Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Treatment Patterns, Clinical Outcomes and EGFR / T790M Testing Practices in EGFR-Mutated Advanced Non-Small Cell Lung Cancer Patients Receiving First-Line TKI Therapy

NCT04031898 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04031898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04031898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Treatment Patterns, Clinical Outcomes and EGFR / T790M Testing Practices in EGFR-Mutated Advanced Non-Small Cell Lung Cancer Patients Receiving First-Line TKI Therapy
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 7, 2019
Completion date
December 31, 2019
Enrollment
896 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer